Travel Medicine and Infectious Disease
Volume 8, Issue 1 , Pages 47-50, January 2010

Quadrivalent meningococcal vaccines: Hyporesponsiveness as an important consideration when choosing between the use of conjugate vaccine or polysaccharide vaccine

Novartis Vaccines and Diagnostics GmbH, Global Medical Affairs, Emil-von-Behring-Straße 76, 35041 Marburg, Germany

Received 23 July 2009; received in revised form 7 December 2009; accepted 9 December 2009. published online 11 January 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1477-8939(09)00179-3

doi:10.1016/j.tmaid.2009.12.001

Travel Medicine and Infectious Disease
Volume 8, Issue 1 , Pages 47-50, January 2010

Article Tools

* Image Usage & Resolution